STRATEC Biomedical AG (SBSG)

Currency in EUR
29.20
+0.10(+0.34%)
Delayed Data·
SBSG Scorecard
Full Analysis
Valuation implies a strong free cash flow yield
SBSG is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
29.2029.20
52 wk Range
21.8044.40
Key Statistics
Bid/Ask
29.20 / 29.35
Prev. Close
29.1
Open
29.2
Day's Range
29.2-29.2
52 wk Range
21.8-44.4
Volume
-
Average Volume (3m)
115
1-Year Change
-29.37%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
SBSG Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

STRATEC Biomedical AG News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

STRATEC Biomedical AG Company Profile

Stratec SE, together with its subsidiaries, provides automation solutions for in-vitro diagnostics and life science companies in Germany, the European Union, and internationally. The company designs and manufactures automated analyzer systems for clinical diagnostics and biotechnology customers. It also provides consumables for diagnostics and medical applications; and integrating instrumentation and software. The company was formerly known as STRATEC Biomedical AG and changed its name to Stratec SE in December 2018. Stratec SE was founded in 1979 and is headquartered in Birkenfeld, Germany.

Employees
1387
Market
Germany

Compare SBSG to Peers and Sector

Metrics to compare
SBSG
Peers
Sector
Relationship
P/E Ratio
22.2x21.3x−0.5x
PEG Ratio
4.820.120.00
Price/Book
1.5x2.2x2.6x
Price / LTM Sales
1.4x1.7x3.2x
Upside (Analyst Target)
40.9%34.6%41.2%
Fair Value Upside
Unlock24.7%6.2%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 1.32%
Dividend Yield
2.06%
Industry Median 1.81%
Annualised payout
0.60
Paid annually
5-Years Growth
-6.51%
Growth Streak

Earnings

Latest Release
May 30, 2025
EPS / Forecast
0.12 / --
Revenue / Forecast
60.40M / --
EPS Revisions
Last 90 days

SBSG Income Statement

People Also Watch

93.35
HAGG
+2.13%
63.210
CRDI
+2.48%
143.70
ENX
-0.07%
574.70
MUVGn
+0.75%
234.30
TCFP
+2.00%

FAQ

What Stock Exchange Does STRATEC Biomedical AG Trade On?

STRATEC Biomedical AG is listed and trades on the Frankfurt Stock Exchange stock exchange.

What Is the Stock Symbol for STRATEC Biomedical AG?

The stock symbol for STRATEC Biomedical AG is "SBSG."

What Is the STRATEC Biomedical AG Market Cap?

As of today, STRATEC Biomedical AG market cap is 356.17M.

What Is STRATEC Biomedical AG's Earnings Per Share (TTM)?

The STRATEC Biomedical AG EPS (TTM) is 1.32.

When Is the Next STRATEC Biomedical AG Earnings Date?

STRATEC Biomedical AG will release its next earnings report on 18 Aug 2025.

From a Technical Analysis Perspective, Is SBSG a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has STRATEC Biomedical AG Stock Split?

STRATEC Biomedical AG has split 1 times.

How Many Employees Does STRATEC Biomedical AG Have?

STRATEC Biomedical AG has 1387 employees.

What is the current trading status of STRATEC Biomedical AG (SBSG)?

As of 29 Jul 2025, STRATEC Biomedical AG (SBSG) is trading at a price of 29.20, with a previous close of 29.10. The stock has fluctuated within a day range of 29.20 to 29.20, while its 52-week range spans from 21.80 to 44.40.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.